Licensed Practical Nurse in Negaunee, MI Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Jennifer Lahti, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Malton Rd Ste 7, Negaunee, MI 49866 Phone: 906-464-0002

Leslie Parkkonen, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Malton Rd, Negaunee, MI 49866 Phone: 906-485-2347

Emily Roberts, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Malton Rd Ste 6, Negaunee, MI 49866 Phone: 906-485-2347

Delaney Mclaughlin, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Malton Rd, Negaunee, MI 49866 Phone: 906-464-0002

Tracey Rae Symons, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 178 Midway Dr, Negaunee, MI 49866 Phone: 906-251-8228

Carrie Malette, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 100 Malton Rd, Negaunee, MI 49866 Phone: 906-464-0002

News Archive

Novel drug can simultaneously help diagnose, treat gastric cancer

A novel drug, named "FerriIridium", can simultaneously help diagnose and treat gastric cancer. The initially weakly active precursor (prodrug), based on an iridium-containing compound, is selectively activated only after reaching the interior of a tumor cell. This is possible because of the higher amount of iron present there, report scientists in the journal Angewandte Chemie.

EMA CHMP adopts positive opinion for Pfizer's axitinib to treat advanced renal cell carcinoma

Pfizer announced today that the Committee for Human Medicinal Products (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion regarding the marketing authorization of axitinib in the European Union (EU), for the treatment of adult patients with advanced renal cell carcinoma (RCC), a type of advanced kidney cancer, after failure of prior treatment with sunitinib or a cytokine.

Proton therapy reduces treatment side effects among head and neck cancer patients

The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.

Medtronic announces new M-Link cellular accessory

Medtronic, Inc. announced today that it now offers the new Medtronic M-Link™ cellular accessory, which provides cardiac device patients with an option to securely send information stored in their implanted devices to their clinics via the CareLink® Network using cellular signals, rather than a telephone landline. This simplified connection to the CareLink® Network enables clinicians to remotely monitor more patients who are implanted with cardiac devices.

Read more Medical News

› Verified 3 days ago